加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRC 加州资源

已收盘 05-08 16:00:00 EDT

50.09

-2.85

-5.38%

盘后50.09

+0.000.00%

17:14 EDT

最高54.51	最低49.80	成交量135.16万
今开54.51	昨收52.94	日振幅8.90%
总市值34.44亿	流通市值32.29亿	总股本6,876万
成交额6,833万	换手率2.10%	流通股本6,446万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRC","market":"US","secType":"STK","nameCN":"加州资源","latestPrice":50.09,"timestamp":1715198400000,"preClose":52.94,"halted":0,"volume":1351556,"hourTrading":{"tag":"盘后","latestPrice":50.09,"preClose":50.09,"latestTime":"17:14 EDT","volume":25325,"amount":1268528.92,"timestamp":1715202898784},"delay":0,"floatShares":64457016,"shares":68761684,"eps":7.78,"marketStatus":"已收盘","marketStatusCode":5,"change":-2.85,"latestTime":"05-08 16:00:00 EDT","open":54.51,"high":54.51,"low":49.8,"amount":68326616.08624,"amplitude":0.088969,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":7.78,"exchange":"NYSE","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1715241600000},"adr":0,"listingDate":1415854800000,"adjPreClose":52.94,"adrRate":0,"dividendRate":0.023108,"preHourTrading":{"tag":"盘前","latestPrice":52.94,"preClose":52.94,"latestTime":"08:20 EDT","volume":1,"amount":52.94,"timestamp":1715170802820},"postHourTrading":{"tag":"盘后","latestPrice":50.09,"preClose":50.09,"latestTime":"17:14 EDT","volume":25325,"amount":1268528.92,"timestamp":1715202898784},"volumeRatio":2.843081},"requestUrl":"/m/hq/s/CRC","defaultTab":"news","newsList":[{"id":"2433720193","title":"加州资源盘中异动 早盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2433720193","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2433720193?lang=zh_cn&edition=full","pubTime":"2024-05-08 23:02","pubTimestamp":1715180548,"startTime":"0","endTime":"0","summary":"北京时间2024年05月08日23时02分，加州资源股票出现异动，股价大幅下跌5.04%。截至发稿，该股报50.27美元/股，成交量21.6856万股，换手率0.32%，振幅7.79%。机构评级方面，在所有8家参与评级的机构中，63%的券商给予买入建议，37%的券商给予持有建议，无券商给予卖出建议。加州资源股票所在的油气勘探开发行业中，整体涨幅为0.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082302287a58c612&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405082302287a58c612&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433751322","title":"加州资源公司公布截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2433751322","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433751322?lang=zh_cn&edition=full","pubTime":"2024-05-08 07:10","pubTimestamp":1715123450,"startTime":"0","endTime":"0","summary":"   * 加州资源公司  公布了截至 3 月份的季度调整后每股收益 75 美分，低于去年同期的每股收益 2.63 美元。华尔街预期为每股收益 57 美分至 68 美分。* 加州资源公司公布的本季度每股收益为亏损 14 美分。* 该公司的季度亏损额为 1,000 万美元。* 加州资源公司股价本季度下跌了 4.4%，今年迄今为止下跌了 3.6%。华尔街对加州资源公司 12 个月目标价的中位数为 62.50 美元  本摘要由 LSEG 于世界协调时 5 月 7 日晚上 11:10 的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432169635","title":"加州资源公司  预计每股收益63美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432169635","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432169635?lang=zh_cn&edition=full","pubTime":"2024-05-04 10:27","pubTimestamp":1714789662,"startTime":"0","endTime":"0","summary":"   * 加州资源公司   将于5月7日公布截至2024年3月31日的业绩报告，预计该公司的季度收入将出现下降。* LSEG 分析师对加州资源公司的平均预期为每股收益 63 美分。* 华尔街对加州资源公司 12 个月目标价的中位数为 62.50 美元，高于其最新收盘价 51.68 美元。5月4日 - 该公司在 2024 年 2 月 27 日发布的截至 3 月 31 日的业绩指引中，资本支出在 6500 万美元至 7500 万美元之间。除非另有说明，所有数字均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432444908","title":"Guardant Health, Inc.盘中异动 早盘大幅上涨5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432444908","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432444908?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:37","pubTimestamp":1714743424,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时37分，Guardant Health, Inc.股票出现异动，股价急速拉升5.22%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为1.12%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是液体癌症检测领域的领先者，用于临床和研究用途。此外，Guardant还提供研究开发服务，如监管批准咨询和临床试验转诊。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321370487e85799&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050321370487e85799&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432970101","title":"Nextcure, Inc.盘中异动 早盘股价大涨7.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432970101","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432970101?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743124,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Nextcure, Inc.股票出现波动，股价大幅上涨7.38%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132048b707f32&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132048b707f32&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432506599","title":"Nextcure, Inc.盘中异动 股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432506599","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432506599?lang=zh_cn&edition=full","pubTime":"2024-05-01 22:26","pubTimestamp":1714573565,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日22时26分，Nextcure, Inc.股票出现波动，股价急速拉升5.49%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012226057a57dcb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012226057a57dcb0&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431960098","title":"Guardant Health, Inc.盘中异动 股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431960098","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431960098?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:17","pubTimestamp":1714403866,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时17分，Guardant Health, Inc.股票出现波动，股价快速拉升5.19%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.95%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是一家临床和研究用液体癌症测试领域的领导者。2021 年，Guardant 推出了 Reveal，一种与肿瘤无关的分子残留病测试。该信息摘要如下：加拿大投资银行集团：维持Guardant Health评级，由买入调整至买入评级, 目标价由45.00美元调整至30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923174687e84c7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042923174687e84c7d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431586464","title":"Nextcure, Inc.盘中异动 早盘大幅上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2431586464","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431586464?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:12","pubTimestamp":1714399938,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时12分，Nextcure, Inc.股票出现波动，股价急速拉升5.19%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.01%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292212187924f1a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404292212187924f1a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430164236","title":"Nextcure, Inc.盘中异动 急速跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430164236","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430164236?lang=zh_cn&edition=full","pubTime":"2024-04-26 00:05","pubTimestamp":1714061102,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日00时05分，Nextcure, Inc.股票出现波动，股价大幅跳水5.56%。Nextcure, Inc.股票所在的生物技术行业中，整体跌幅为1.54%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600050279238046&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042600050279238046&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430281142","title":"Guardant Health, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430281142","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430281142?lang=zh_cn&edition=full","pubTime":"2024-04-25 22:01","pubTimestamp":1714053663,"startTime":"0","endTime":"0","summary":"北京时间2024年04月25日22时01分，Guardant Health, Inc.股票出现波动，股价大幅下跌5.13%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为1.35%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是一家临床和研究用液体癌症测试领域的领导者。2021 年，Guardant 推出了 Reveal，一种与肿瘤无关的分子残留病测试。此外，Guardant 还提供研究开发服务，例如监管审批咨询和临床试验转介。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522010379237896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042522010379237896&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429164261","title":"Nextcure, Inc.盘中异动 早盘股价大涨5.59%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429164261","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429164261?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:53","pubTimestamp":1713883987,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时53分，Nextcure, Inc.股票出现异动，股价急速上涨5.59%。截至发稿，该股报1.70美元/股，成交量4.3148万股，换手率0.15%，振幅7.45%。Nextcure, Inc.股票所在的生物技术行业中，整体涨幅为1.59%。Nextcure, Inc.公司简介：NextCure Inc 是一家临床阶段生物制药公司，致力于发现和开发新型，一流的免疫药物，通过恢复正常的免疫功能来治疗癌症和其他免疫相关疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225307861e8355&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240423225307861e8355&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429299119","title":"Guardant Health, Inc.盘中异动 股价大涨5.29%报16.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429299119","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429299119?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:30","pubTimestamp":1713792659,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时30分，Guardant Health, Inc.股票出现波动，股价急速上涨5.29%。Guardant Health, Inc.股票所在的生命科学行业中，整体涨幅为0.15%。其相关个股中，Ispecimen Inc.、23Andme Holding Co.、Guardant Health, Inc.涨幅较大，T2 Biosystems, Inc.、Ispecimen Inc.、Check-Cap Ltd.较为活跃，换手率分别为6.61%、1.77%、0.13%，振幅较大的相关个股有Ispecimen Inc.、Check-Cap Ltd.、Volitionrx Limited，振幅分别为6.10%、5.31%、4.06%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是一家临床和研究用液体癌症测试领域的领导者。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221310087e827d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221310087e827d6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428938526","title":"Guardant Health, Inc.盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428938526","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428938526?lang=zh_cn&edition=full","pubTime":"2024-04-20 02:57","pubTimestamp":1713553046,"startTime":"0","endTime":"0","summary":"北京时间2024年04月20日02时57分，Guardant Health, Inc.股票出现波动，股价急速跳水5.00%。Guardant Health, Inc.股票所在的生命科学行业中，整体跌幅为0.10%。Guardant Health, Inc.公司简介：Guardant Health, Inc 总部位于加利福尼亚州雷德伍德城，是一家临床和研究用液体癌症测试领域的领导者。2021 年，Guardant 推出了 Reveal，一种与肿瘤无关的分子残留病测试。此外，Guardant 还提供研究开发服务，例如监管审批咨询和临床试验转介。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420025727861e782b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240420025727861e782b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428754510","title":"Check-Cap Ltd.盘中异动 股价大涨6.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428754510","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428754510?lang=zh_cn&edition=full","pubTime":"2024-04-19 02:44","pubTimestamp":1713465873,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日02时44分，Check-Cap Ltd.股票出现异动，股价急速上涨6.88%。截至发稿，该股报2.33美元/股，成交量8718股，换手率0.15%，振幅7.34%。Check-Cap Ltd.股票所在的生命科学行业中，整体跌幅为1.06%。Check-Cap Ltd.公司简介：Check-Cap Ltd 是一家临床阶段的医疗诊断公司，致力于开发可摄取的成像胶囊，该胶囊利用低剂量 X 射线对结肠息肉和结直肠癌  进行检测和成像。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419024434861e7218&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419024434861e7218&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428514666","title":"盛禾生物2023年亏损1.3亿元：同比扩大155%，董事长张峰为实控人","url":"https://stock-news.laohu8.com/highlight/detail?id=2428514666","media":"贝多财经","top":-1,"share":"https://www.laohu8.com/m/news/2428514666?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:40","pubTimestamp":1713451219,"startTime":"0","endTime":"0","summary":"近日，盛禾生物控股有限公司（下称“盛禾生物”，Sunho Biologics, Inc - B）通过港交所上市聆讯，并披露了截至2023年12月31日的财务数据等信息。相关消息称，盛禾生物正进行启动IPO预路演，募资规模约5000万美元（约3.9亿港元，人民币约3.6亿元）。据贝多财经了解，盛禾生物于2023年8月、2024年2月分别进行了递表，中金公...","market":"us","thumbnail":"https://inews.gtimg.com/om_ls/OplQ4IsoUd2uvDCekh68n-Twn4XBBNc1tKeM79jnUFUcoAA_294195/0","type":0,"news_type":0,"thumbnails":["https://inews.gtimg.com/om_ls/OplQ4IsoUd2uvDCekh68n-Twn4XBBNc1tKeM79jnUFUcoAA_294195/0"],"rights":{"source":"tencent_tech","url":"https://new.qq.com/rain/a/20240418A0A2CS00","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.title{#titleStyle#}a{#lv2TextColor#}.author, .pubtime{#sourceStyle#; display: inline-block;} .pubtime{margin-left: 3px;}strong{font-weight:500;#lv2TextColor#}","selectors":".main-wrapper","filters":".follow_top, .channel-entry, .collapseWrapper, .pic, .gap, .showDividingLine, .loader, .container, .ct-sumary, .nav, .landad, .hairline-top, .footer, .recommend-modules, .headroom-wrapper, .elevator","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://new.qq.com/rain/a/20240418A0A2CS00","is_publish_highlight":false,"gpt_icon":0},{"id":"2428360590","title":"美国研究综述-3M、J&J、Nuvalent","url":"https://stock-news.laohu8.com/highlight/detail?id=2428360590","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2428360590?lang=zh_cn&edition=full","pubTime":"2024-04-17 15:48","pubTimestamp":1713340130,"startTime":"0","endTime":"0","summary":"    路透社4月17日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 3M、J&J 和 Nuvalent。要闻              * 3M公司  ：摩根大通将目标价从118美元下调至110美元             * J&J   ：加拿大皇家银行将目标价从181美元下调至175美元             * Nuvalent Inc   ：Jefferies给予买入评级，目标价97美元             * Tractor Supply Co   ：巴克莱将目标价从192美元上调至234美元             * UnitedHealth Group Inc   ：Piper Sandler将目标价从566美元上调至571美元 以下是路透社周三报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428376109","title":"盛禾生物通过港交所聆讯，专注肿瘤免疫疗法，在研九个管线产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2428376109","media":"独角兽早知道","top":-1,"share":"https://www.laohu8.com/m/news/2428376109?lang=zh_cn&edition=full","pubTime":"2024-04-17 08:10","pubTimestamp":1713312600,"startTime":"0","endTime":"0","summary":"独角兽早知道 iponews｜资讯撬动新资本｜4月15日，盛禾生物控股有限公司通过港交所主板上市聆讯，中金公司担任独家保荐人。盛禾生物还将扩大公司的国际注册团队，以确保进行公司的全球临床开发和注册计划，并强化公司的主打产品，特别是公司的抗体细胞因子管线产品，包括IAP0971、IAE0972和 IBB0979。尤其是各类免疫疗法，包括用于治疗癌症和自身免疫性疾病的抗体细胞因子。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU3MTY1MzExOQ==&mid=2247575633&idx=2&sn=0dfe4b11c3629e6ddace06df38435f6d&chksm=fcdf06c1cba88fd7a8c45c6b0690e44bbc086aeedb92348bbbaae8376e079511ebd9674608a0#rd","is_publish_highlight":false,"gpt_icon":0},{"id":"2428804562","title":"Check-Cap Ltd.盘中异动 下午盘急速拉升8.25%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428804562","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428804562?lang=zh_cn&edition=full","pubTime":"2024-04-17 03:19","pubTimestamp":1713295176,"startTime":"0","endTime":"0","summary":"北京时间2024年04月17日03时19分，Check-Cap Ltd.股票出现异动，股价快速拉升8.25%。截至发稿，该股报2.36美元/股，成交量1.1294万股，换手率0.19%，振幅5.05%。Check-Cap Ltd.股票所在的生命科学行业中，整体跌幅为0.44%。Check-Cap Ltd.公司简介：Check-Cap Ltd 是一家临床阶段的医疗诊断公司，致力于开发可摄取的成像胶囊，该胶囊利用低剂量 X 射线对结肠息肉和结直肠癌  进行检测和成像。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417031936861e65ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240417031936861e65ed&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427584350","title":"新股解读|盛禾生物：两年累计亏损约2亿元 抗HER2抗体能否造就致富故事？","url":"https://stock-news.laohu8.com/highlight/detail?id=2427584350","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427584350?lang=zh_cn&edition=full","pubTime":"2024-04-16 17:11","pubTimestamp":1713258687,"startTime":"0","endTime":"0","summary":"根据智通财经APP了解，盛禾生物的IAH0968是自主研发的首个100%去除岩藻糖的临床阶段抗HER2抗体。对于盛禾生物而言，抗HER2抗体带给其一定的想象空间。马吉妥昔单抗、玛格妥昔单抗、帕捷特及赫赛汀已获FDA批准。这两种抗体专用于对以往治疗方案无响应的HER2阳性乳腺癌。市场规模来看，全球抗HER2单克隆抗体市场将在2026年及2030年分别达到136亿美元及148亿美元。在全球范围内，2种基于抗体药物获批准用于治疗BTC。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103318.html","is_publish_highlight":false,"gpt_icon":1},{"id":"2427085864","title":"新股消息 | 盛禾生物通过港交所聆讯 拥有三种核心产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2427085864","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2427085864?lang=zh_cn&edition=full","pubTime":"2024-04-16 06:40","pubTimestamp":1713220835,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，据港交所4月15日披露，盛禾生物控股有限公司通过港交所主板上市聆讯，中金公司为其独家保荐人。拥有三种核心产品，即IAH0968、IAP0971及IAE0972，均为内部研发。截至最后实际可行日期，有九种管线产品，除核心产品外，其中三种处于临床阶段，亦专注于癌症治疗。公司核心产品IAH0968是自主研发的首个100%去除岩藻糖的临床阶段抗HER2抗体。其旨在阻断EGFR信号通路，特异性地将IL-10传递到靶向肿瘤部位，以激活CD8+T细胞，并可能激活NK细胞。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103015.html","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crc.com","stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":-0.0334},{"period":"3month","weight":-0.0053},{"period":"6month","weight":0.0446},{"period":"1year","weight":0.3335},{"period":"ytd","weight":-0.0318}],"compareEarnings":[{"period":"1week","weight":0.0302},{"period":"1month","weight":-0.0025},{"period":"3month","weight":0.0382},{"period":"6month","weight":0.192},{"period":"1year","weight":0.2529},{"period":"ytd","weight":0.088}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"California Resources Corporation于2014年4月23日在特拉华州注册成立。该公司从Occidental公司分离出来之后是一家独立的石油和天然气勘探和生产公司，专注于高增长，高回报在加利福尼亚州的常规和非常规资产。加利福尼亚州是世界上最丰富的石油和天然气生产地区之一，是全国第三大石油生产州。该公司在加利福尼亚州的总经营的基础上是最大的生产商。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.042312},{"month":2,"riseRate":0.5,"avgChangeRate":0.046827},{"month":3,"riseRate":0.5,"avgChangeRate":-0.007775},{"month":4,"riseRate":0.25,"avgChangeRate":-0.02618},{"month":5,"riseRate":0.75,"avgChangeRate":0.059632},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042337},{"month":7,"riseRate":0.666667,"avgChangeRate":0.091936},{"month":8,"riseRate":1,"avgChangeRate":0.126025},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.009987},{"month":10,"riseRate":0.666667,"avgChangeRate":0.079295},{"month":11,"riseRate":0.5,"avgChangeRate":0.113764},{"month":12,"riseRate":0.75,"avgChangeRate":0.050209}],"exchange":"NYSE","name":"加州资源","nameEN":"California Resources"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"加州资源,CRC,加州资源股票,加州资源股票老虎,加州资源股票老虎国际,加州资源行情,加州资源股票行情,加州资源股价,加州资源股市,加州资源股票价格,加州资源股票交易,加州资源股票购买,加州资源股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"加州资源(CRC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供加州资源(CRC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}